Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Greenwich Lifesciences Inc GLSI

Healthcare Biotechnology
Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of GP2, immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the human epidermal growth factor receptor 2 (HER2)/neu protein, a cell surface receptor protein that is expressed in a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GLSI)

Greenwich LifeSciences Partners with GIM in Italy

GlobeNewswire 5 days ago

Greenwich LifeSciences Provides Update on Corporate Events

GlobeNewswire 13 days ago

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain

GlobeNewswire August 1, 2024

Greenwich LifeSciences Set to Join Russell 2000 Index Again

GlobeNewswire June 26, 2024

Greenwich LifeSciences Announces $2.5 Million Private Placement

GlobeNewswire June 14, 2024

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

GlobeNewswire March 13, 2024

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

GlobeNewswire March 12, 2024

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

GlobeNewswire February 27, 2024

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

GlobeNewswire February 22, 2024
View More News ››

Opinion & Analysis (NDAQ:GLSI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:GLSI)

Greenwich LifeSciences Inc. (NASDAQ: GLSI) Near the Top of E

BREAKING NEWS: $GLSI Greenwich LifeSciences Inc. (NASDAQ: GLSI) Near the Top of Equities by Percentage Gain on 2/14Greenwich...
whytestocks - February 14, 2024

HERE’S WHY YOU SHOULD KEENLY WATCH GREENWICH LIFESCIENCES

$GLSI Greenwich LifeSciences, Inc. (NASDAQ: GLSI), a clinical-stage pharmaceutical company, developing immunotherapy to prevent breast...
AviseAnalytics - July 14, 2022

RE:RE:Wow

wow proud of you all, i passed on this last month!
north40 - December 10, 2020

RE:Wow

Absolutely, best to you people. This type of movement is virtually unheard of atlest in one day. Good job ,hope it's in TFSA too...
slyder3 - December 9, 2020

Wow

Congratulations to whoever got rich today. :) 
Bunge - December 9, 2020

Launches First-to-Market Fan Engagement Experience

bBooth, Inc. (BBTH) Launches First-to-Market Fan Engagement Experience Through Its Video-Sharing App Songstagram (Soon-to-Be-Named '...
StockMountie - March 12, 2015
View more Bullboard ››

Innocan Pharma Corp

Innocan Pharma Corp

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the ...
View More »